PHOTODYNAMIC THERAPY IN THE TREATMENT OF PANCREATIC CARCINOMA: DIHEMATOPORPHYRIN ETHER UPTAKE and PHOTOBLEACHING KINETICS

Abstract Results of dihematoporphryin ether (DHE) uptake and fluorescence kinetics show that the concentration in the pancreas is on the order of 40‐60 μg DHE g−1 of tissue at an injected dose of 40 mg kg−1. Previously concentrations on this order have primarily been found in organs of the reticuloendothelial system. Two intra‐pancreatic carcinoma models, one of acinar origin (rat) and one of ductal origin (hamster), were studied. Both showed equal or higher concentrations of DHE as compared with normal pancreas when fluorescence measurements and chemical extraction procedures were performed. Photodynamic therapy (PDT) treatment of the normal pancreas and pancreatic tumors yielded atypical results. When the normal pancreas with DHE present is exposed to 630‐nm light from a dye laser (75 mW cm−2, 30 min), the normal photobleaching measurable by fluorescence decay does not occur. Yet the pancreatic tumor responds with a relatively normal fluorescence decay pattern, with hemorrhaging and a resultant loss of measurable DHE concentration.

[1]  D. Bockman,et al.  Cells of origin of pancreatic cancer: Experimental animal tumors related to human pancreas , 1981, Cancer.

[2]  T. Dougherty,et al.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.

[3]  J. Yager,et al.  Pancreatic carcinoma in azaserine‐treated rats: Induction, classification and dietary modulation of incidence , 1981, Cancer.

[4]  D. Longnecker,et al.  Experimental induction of pancreatic carcinomas in the hamster with N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine. , 1983, Journal of the National Cancer Institute.

[5]  J. Moan,et al.  Porphyrin-sensitized photoinactivation of cells in vitro. , 1984, Progress in clinical and biological research.

[6]  D. Longnecker,et al.  Transplantation of azaserine-induced carcinomas of pancreas in rats. , 1979, Cancer letters.

[7]  D. Longnecker Animal model of human disease. Carcinoma of the pancreas in azaserine-treated rats. , 1981, The American journal of pathology.

[8]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[9]  Longnecker Ds Animal model of human disease. Carcinoma of the pancreas in azaserine-treated rats. , 1981 .

[10]  T. Mang,et al.  Photofrin II levels by in vivo fluorescence photometry. , 1984, Progress in clinical and biological research.

[11]  E. Silverberg,et al.  Cancer statistics, 1986 , 1986, CA: a cancer journal for clinicians.

[12]  E. Land,et al.  Porphyrin localization and treatment of tumors , 1985, British Journal of Cancer.